SSScott Strayer

Scott Strayer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Scott Strayer has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing efficacy of a web-based smoking cessation tool - QuitAdvisorMD: Protocol for a practice-based, clustered, randomized control trial

    by Scott M. Strayer, Austin Barnhardt, Lisa K. Rollins, Karen Ingersoll, Guofen Yan, Kurtis S. Elward, John B. Schorling


  • Open Access

    Smoking cessation counseling decision aid with E-cigarette information: A feasibility test

    by Scott Strayer, Ramzi Salloum, Jennifer LeLaurin, Christy Kollath-Cattano, Allie Kellner, James Thrasher

    Context: E-cigarette use has been increasing rapidly, most prominently among adult smokers. Smokers are more likely to use e-cigarettes to help them quit smoking than FDA-recommended methods (e.g., nicotine replacement therapy or prescription medications). Since at least 70% of smokers visit their physician annually, clinical encounters in primary care present a critical opportunity to provide smokers with evidence-based information about e-cigarettes. Objective: Enhance a previously developed prototype decision aid (DA) for smoking cessation counseling in primary care settings incorporating messages based on the behavior change approach of Motivational Interviewing (MI) and conduct focus groups physicians to further refine and inform the design of the enhanced DA. Study Design: Qualitative study. Setting or Dataset: Health system primary care practices. Population studied: Board-certified primary care physicians, PGY2 or 3 residents, nurse practitioners and physician assistants (N=10). Outcome Measures: Develop an enhanced smoking cessation DA incorporating MI-based content. Results: While most participants had formal training in MI techniques during residency, and sometimes used it for smoking cessation counseling, some still found it challenging to engage smokers in discussions about smoking cessation when they did not want to quit (i.e., precontemplation stage). Physicians acknowledged that time constraints and competing priorities (i.e., patient comorbidities) sometimes limited their ability to use MI techniques. Most physicians were familiar with DAs, although prior experience using them in practice was lacking, and only one participant had used them with patients. Physicians in both focus groups expressed interest in using the DA with patients and commented that it had the potential to improve cessation counseling by spending time building off DA content and getting into the “real work” of smoking cessation and employing MI techniques, rather than focusing on “standard” questions that would have already been answered in the DA. Conclusions: An MI-based DA for smoking cessation counseling appears promising for use in primary care settings. Effective implementation will require addressing physician lack of knowledge and experience with using DAs and with discussing e-cigarettes with patients.

  • Open Access

    Feasibility of a primary care patient decision aid for smoking cessation with information about e-cigarettes

    by Jennifer LeLaurin, Allie Kellner, Christy Kollath-Cattano, Scott Strayer, Ramzi Salloum, James Thrasher

    Context: Patients who smoke are increasingly using e-cigarettes for smoking cessation. Decision aids can promote the delivery of evidence-based smoking cessation treatment in primary care settings; however, more information is needed on the impact of smoking cessation decision aids which include information on switching completely from cigarettes to e-cigarettes. Objective: To assess the feasibility and acceptability of a smoking cessation decision aid that includes e-cigarette information. Study Design: Pre-post. Setting: Primary care. Population Studied: Adult patients who are current cigarette smokers (N=120). Intervention: In Phase I (N=60), all patients were shown a decision aid with information about FDA-approved cessation methods (i.e., nicotine replacement therapy, prescription medications) prior to their clinic visit. In Phase II (N=60), current smokers who were e-cigarette users and those with no intention of quitting cigarettes received decision aids with additional information on switching to e-cigarettes. Outcome Measures: Quit attempts and abstinence, confidence and readiness to quit, confidence and readiness to switch to e-cigarettes, and patient satisfaction. Results: Patients reported higher confidence and readiness to quit after viewing the decision aid and consulting with their physician across both phases (p<.05). Patients reported the decision aid helped prepare them to make a decision about quitting smoking and expressed satisfaction with the decision aid and physician consultation. There was no impact of including e-cigarette information in the decision aids on any measured outcomes. Conclusions: Smoking cessation decision aids are acceptable to patients and may promote behavior change. Further research is needed to identify strategies to promote shared decision-making regarding e-cigarettes. Future studies should explore the impact of providing patients e-cigarette information using larger sample sizes and rigorous designs.